1803171-55-2(Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer)
1803171-55-2 Basic informationMore
- Product Name:Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer
- Synonyms: Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer Ravulizumab Research Grade Ravulizumab (DHB90001) Ravulizumab (anti-Complement C5) ALXN1210
- CAS:1803171-55-2
- MF:
- MW:0
- EINECS:
- Mol File:Mol File
-
Recommend You Select Member Companies
- Company Name:Aladdin Scientific
- Tel:+1-+1(833)-552-7181
- Nationality:United States
- Products Intro:Product Name:Ravulizumab (anti-Complement C5)
CAS:1803171-55-2
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:$89.9/100μg;$429.9/1mg;$1119.9/5mg;$1779.9/10mg;Bulk package Remarks:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated - CB Index:58
- Related Information:Catalog(57511)